231 Note 20 Trade payables (continued) Trade payables ageing (` cr) No. Particulars As at March 31, 2023 Unbillied Not due Less than 1 year 1-2 years 2-3 years More than 3 years Total 1. MSME - 43.08 2.81 0.05 0.19 - 46.13 2. Others 96.28 325.99 69.74 0.20 0.17 - 492.38 96.28 369.07 72.55 0.25 0.36 - 538.51 (` cr) No. Particulars As at March 31, 2022 Unbillied Not due Less than 1 year 1-2 years 2-3 years More than 3 years Total 1. MSME - 43.89 0.54 0.24 - - 44.67 2. Others 75.13 399.75 113.91 1.16 0.06 0.05 590.06 75.13 443.64 114.45 1.40 0.06 0.05 634.73 (` cr) Note 21 Contract liabilities As at March 31, 2023 As at March 31, 2022 Advances received from customers 36.95 33.82 36.95 33.82 (` cr) Note 22 Revenue from operations 2022-23 2021-22 Sale of products 5,180.68 4,825.13 Sale of services1 185.64 190.74 Scrap sales 14.13 15.42 Commission received 0.05 0.02 Processing charges - 8.35 Revenue from contracts with customers 5,380.50 5,039.66 Export incentives 47.02 41.23 5,427.52 5,080.89 1Includes ` 183.37 cr (2021-22: ` 188.52 cr) on account of freight and insurance in sale of goods on CIF, which are identified as separate performance obligation under Ind AS 115. Disaggregation of revenue from contracts with customers (` cr) Particulars 2022-23 2021-22 Sale of goods | services Life Science Chemicals 1,937.50 1,449.36 Domestic 791.53 695.16 Export 1,145.97 754.20 Performance and Other Chemicals 3,680.80 3,733.69 Domestic 2,089.81 2,018.16 Export 1,590.99 1,715.53 Others 49.64 69.97 5,667.95 5,253.02 Inter-segment revenue 287.45 213.36 5,380.50 5,039.66
RkJQdWJsaXNoZXIy MjA2MDI2